WebmedCentral Editor
View all WebmedCentral Editors
 
No Image

Prof. Li Jiao

Assistant Professor
Department of Medicine, Baylor College of Medicine, Houston, TX
 

Brief Biography:


Education

1. 2004: PhD Community Health Sciences Division of Environmental and Occupational Health, The University of Texas School of Public Health, Houston, TX Major: Environmental Health Sciences; Minors: Epidemiology and Biostatistics
2. 1997: Master’s Degree of Medicine Department of Epidemiology, National Institute of Environmental Health and Related Product Safety, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China
3. 1994: Medical Doctoral Degree Tongji Medical University, Wuhan, China

 

Academic positions:


Research Experience

1. Aug 2009 – present: Assistant Professor; Department of Medicine, Baylor College of Medicine, Houston, TX
2. Nov 2006 – Jul 2009: Cancer Research Training Award Fellow; Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Rockville, MD
3. Sep 2004 – Nov 2006: Postdoctoral Fellow; Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
4. Jan 2000 – Aug 2004: Graduate Research Assistant (Doctoral research); Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
5. Feb 1999 – Dec 1999: Research Associate; Department of Health Effect, National Institute of Environmental Health and Related Product Safety, China CDC, Beijing
6. Sep 1997 – Jan 1999: Research Assistant; Department of Health Effect, National Institute of Environmental Health and Related Product Safety, China CDC, Beijing

Awards

1. Outstanding undergraduate student, Tongji Medical University, 1991, 1992
2. Fogarty international traineeship, China CDC, Beijing, 1997.
3. Associate Member of the American Association for Cancer Research, 2001-2012
4. Active Member of the American Association for Cancer Research, 2013-
5. Richard K. Sever scholarship, UT-School of Public Health, Houston, TX, 2002.
6. Cancer Research Training Award, NCI, Rockville, MD, 2006
7. Intramural Innovation Research Award, NCI, Rockville, MD, 2008. $50,000
8. Dan L. Duncan Scholar, Baylor College of Medicine, Houston, TX, 2009-2012

 

Research interests:


Gastroenterology, Hepatology, Cancer

 

Any other information:


Publications

1. Arem H, Reedy J, Sampson J, Jiao L, Hollenbeck AR, Risch H, Mayne ST, Stolzenberg-Solomon RZ. The Healthy Eating Index 2005 and Risk of Pancreatic Cancer in the NIH-AARP Study. Journal of National Cancer Institute. 2013 August.
2. Jiao L, Kramer J, Chen L, Rugge M, Parente P, Verstovsek G, Alsarraj A, El-Serag HB. Dietary Consumption of Meat, Fat, Animal Products and Advanced Glycation End-Products and the Risk of Barrett’s Esophagus. Alimentary Pharmacology and Therapeutics. 2013 (Accepted)
3. Bao Y, Giovannucci E, Kraft P, Qian ZR, Wu C, Ogino S, Gaziano JM, Stampfer MJ, Ma J, Buring JE, Sesso H, Lee IM, Rifai N, Pollak MN, Jiao L, Lessin LS, Cochrane BB, Manson JE, Fuchs CS, Wolpin BM. Inflammatory Plasma Markers and Pancreatic Cancer Risk: a Prospective Study of 5 U.S. Cohorts.Cancer Epidemiol Biomarkers Prev. 2013 Mar 5. [Epub ahead of print]
4. Jiao L, Kramer J, Rugge M, Parente P, Verstovsek G, Alsarraj A, El-Serag HB. Dietary Intake of Vegetables, Folate, and Antioxidants and the Risk of Barrett’s Oesophagus. Cancer Causes and Control. 2013. Feb 19. [Epub ahead of print]
5. Moy KA, Jiao L, Freedman N, Weinstein S, Sinha R, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Advanced glycation end products, soluble receptor for advanced glycation. Hepatology. 2013 Jan 16. doi: 10.1002/hep.26264.
6. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White D, El-Serag HB. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer. 2013, 108: 213-21.038/bjc.2012.561
7. Jiao L, Chen L, Alsarraj A, Ramsey D, Duan Z, El-Serag HB. Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma. Int J Mol Epidemiol Genet. 2012;3(4):294-304.
8. Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo
9. Jiao L, Weinstein SJ, Albanes D, Taylor PR, Graubard BI, Virtamo J, Stolzenberg-Solomon RZ. Evidence that Serum Levels of the Soluble Receptor for Advanced Glycation End-Products are Inversely Associated with Pancreatic Cancer Risk: a Prospective Study. Cancer Research. 2011, 15: 3582-9. PMCID: PMC3096705.
10. Jiao L, Taylor PR, Weinstein SJ, Graubard BI, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Advanced Glycation End-products, Soluble Receptor for Advanced Glycation End-Products and Risk of Colorectal Cancer. Cancer Epidemiology, Biomarkers and Prevention. 2011, 20: 1430-8. PMCID: PMC3132292
11. Tasevska N, Jiao L, Cross AJ, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Potischman N. Sugar in diet and risk of cancer in the NIH-AARP Diet and Health Study. International Journal of Cancer. 2012, 130: 159-69. PMID: 21328345
12. Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer RM, Park Y, Freedman DM, Gail1 MH, Alavanja MCR, Albanes D, Beane Freeman LE, Chow WH, Huang WY, Hayes RB, Hoppin JA, Ji B, Leitzmann MF, Linet MS, Meinhold CL, Schairer C, Schatzkin A, Virtamo J, Weinstein SJ, Zheng W, Stolzenberg-Solomon RZ. Body mass index, effect modifiers, and risk of
pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control. 2010, 8:1305-14.
13. Meinhold CL, Dodd KW, Jiao L, Flood A, Shikany JM, Genkinger J, Hayes RB, Stolzenberg-Solomon R. Available carbohydrate, glycemic load, and pancreatic cancer: Is there a link. American Journal of Epidemiology. 2010, 11: 1174-82.
14. Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ. Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Clinical Nutrition. 2010, 2:449-55.
15. Thiébaut ACM, Jiao L, Silverman D, Cross A, Thompson FE, Subar A, Hollenbeck AR, Schatzkin A, and Stolzenberg-Solomon R. Dietary fatty acids and pancreatic cancer in the NIH-AARP Diet and Health Study. Journal of National Cancer Institute. 2009, 14:1001-11.
16. Jiao L, Silverman D, Schairer C, Thiébaut A, Hollenbeck A, Leitzmann M, Schatzkin A, and Stolzenberg-Solomon R. Alcohol use and risk of pancreatic cancer in the NIH-AARP Diet and Health Study. America Journal of Epidemiology. 2009, 9:1043-51.
17. Jiao L, Flood A, Subar A, Hollenbeck A, Schatzkin A, and Stolzenberg-Solomon R. Glycemic index, available carbohydrate, glycemic load and risk of pancreatic cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiology Biomarkers Prevention. 2009, 18: 1144-1151.
18. Jiao L, Mitrou P, Reedy J, Graubard B, Hollenbeck A, Schatzkin A, and Stolzenberg-Solomon R. Is a combined lifestyle score associated with pancreatic cancer risk? –A large cohort study. Archives of Internal Medicine. 2009, 169: 764-770.
19. Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, and Li D. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. Journal of Clinical Oncology. 2009, 27: 1592-1599.
20. Bao Y, Stolzenberg-Solomon S, Jiao L, Silverman D, Subar A, Park Y, Leitzmann M, Hollenbeck A, Schatzkin A, Michaud D. Added sugar, sugar-sweetened foods and beverages and risk of pancreatic cancer in the NIH-AARP Diet and Health Study. American Journal of Clinical Nutrition. 2008, 88: 2431-2440.

 

What I think of the idea behind WebmedCentral:


.